289 related articles for article (PubMed ID: 33318191)
1. A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.
Suresh BM; Li W; Zhang P; Wang KW; Yildirim I; Parker CG; Disney MD
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33197-33203. PubMed ID: 33318191
[TBL] [Abstract][Full Text] [Related]
2. Design of a small molecule against an oncogenic noncoding RNA.
Velagapudi SP; Cameron MD; Haga CL; Rosenberg LH; Lafitte M; Duckett DR; Phinney DG; Disney MD
Proc Natl Acad Sci U S A; 2016 May; 113(21):5898-903. PubMed ID: 27170187
[TBL] [Abstract][Full Text] [Related]
3. Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs.
Velagapudi SP; Costales MG; Vummidi BR; Nakai Y; Angelbello AJ; Tran T; Haniff HS; Matsumoto Y; Wang ZF; Chatterjee AK; Childs-Disney JL; Disney MD
Cell Chem Biol; 2018 Sep; 25(9):1086-1094.e7. PubMed ID: 30251629
[TBL] [Abstract][Full Text] [Related]
4. Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit.
Costales MG; Haga CL; Velagapudi SP; Childs-Disney JL; Phinney DG; Disney MD
J Am Chem Soc; 2017 Mar; 139(9):3446-3455. PubMed ID: 28240549
[TBL] [Abstract][Full Text] [Related]
5. Identifying and validating small molecules interacting with RNA (SMIRNAs).
Disney MD; Velagapudi SP; Li Y; Costales MG; Childs-Disney JL
Methods Enzymol; 2019; 623():45-66. PubMed ID: 31239057
[TBL] [Abstract][Full Text] [Related]
6. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.
Disney MD; Angelbello AJ
Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012
[TBL] [Abstract][Full Text] [Related]
8. How We Think about Targeting RNA with Small Molecules.
Costales MG; Childs-Disney JL; Haniff HS; Disney MD
J Med Chem; 2020 Sep; 63(17):8880-8900. PubMed ID: 32212706
[TBL] [Abstract][Full Text] [Related]
9. A cross-linking approach to map small molecule-RNA binding sites in cells.
Velagapudi SP; Li Y; Disney MD
Bioorg Med Chem Lett; 2019 Jun; 29(12):1532-1536. PubMed ID: 30987892
[TBL] [Abstract][Full Text] [Related]
10. Precise Small Molecule Degradation of a Noncoding RNA Identifies Cellular Binding Sites and Modulates an Oncogenic Phenotype.
Li Y; Disney MD
ACS Chem Biol; 2018 Nov; 13(11):3065-3071. PubMed ID: 30375843
[TBL] [Abstract][Full Text] [Related]
11. A click chemistry assay to identify natural product ligands for pre-microRNAs.
Garner AL; Lorenz DA; Gallagher EE
Methods Enzymol; 2019; 623():85-99. PubMed ID: 31239059
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer.
Costales MG; Aikawa H; Li Y; Childs-Disney JL; Abegg D; Hoch DG; Pradeep Velagapudi S; Nakai Y; Khan T; Wang KW; Yildirim I; Adibekian A; Wang ET; Disney MD
Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2406-2411. PubMed ID: 31964809
[TBL] [Abstract][Full Text] [Related]
13. General Theory of Fragment Linking in Molecular Design: Why Fragment Linking Rarely Succeeds and How to Improve Outcomes.
Yu HS; Modugula K; Ichihara O; Kramschuster K; Keng S; Abel R; Wang L
J Chem Theory Comput; 2021 Jan; 17(1):450-462. PubMed ID: 33372778
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer using fragment based drug discovery.
Turnbull AP; Boyd SM
Anticancer Agents Med Chem; 2012 Jan; 12(1):40-8. PubMed ID: 21707503
[TBL] [Abstract][Full Text] [Related]
15. From fragment screening to potent binders: strategies for fragment-to-lead evolution.
Eitner K; Koch U
Mini Rev Med Chem; 2009 Jul; 9(8):956-61. PubMed ID: 19601891
[TBL] [Abstract][Full Text] [Related]
16. Low-Molecular Weight Small Molecules Can Potently Bind RNA and Affect Oncogenic Pathways in Cells.
Suresh BM; Akahori Y; Taghavi A; Crynen G; Gibaut QMR; Li Y; Disney MD
J Am Chem Soc; 2022 Nov; 144(45):20815-20824. PubMed ID: 36322830
[TBL] [Abstract][Full Text] [Related]
17. DNA-encoded library versus RNA-encoded library selection enables design of an oncogenic noncoding RNA inhibitor.
Benhamou RI; Suresh BM; Tong Y; Cochrane WG; Cavett V; Vezina-Dawod S; Abegg D; Childs-Disney JL; Adibekian A; Paegel BM; Disney MD
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35110406
[TBL] [Abstract][Full Text] [Related]
18. Discovery of selective ligands for telomeric RNA G-quadruplexes (TERRA) through 19F-NMR based fragment screening.
Garavís M; López-Méndez B; Somoza A; Oyarzabal J; Dalvit C; Villasante A; Campos-Olivas R; González C
ACS Chem Biol; 2014 Jul; 9(7):1559-66. PubMed ID: 24837572
[TBL] [Abstract][Full Text] [Related]
19. Small molecule chemical probes of microRNA function.
Velagapudi SP; Vummidi BR; Disney MD
Curr Opin Chem Biol; 2015 Feb; 24():97-103. PubMed ID: 25500006
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.
Di Giorgio A; Tran TP; Duca M
Future Med Chem; 2016 May; 8(7):803-16. PubMed ID: 27149207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
